Monday, October 24, 2016

Nature Reviews Cancer contents November 2016 Volume 16 Number 11 pp675-749

If you are unable to see the message below, click here to view.

Nature Reviews Cancer


Advertisement
The Naturejobs Career Expo is returning to Düsseldorf.
 
Friday 18, November 2016

This free career fair offers talented scientists an excellent opportunity to meet a diverse selection of national and international employers from academic institutions and scientific industries, such as pharmaceutical organisations, digital technology companies, science publishing and much more.

Register free today!
 
TABLE OF CONTENTS
 
November 2016 Volume 16 Number 11Advertisement
Nature Reviews Cancer cover
Impact Factor 34.244 *
In this issue
Research Highlights
Focus on: Tumour metabolism
Reviews

Also this month
 Featured article:
Altered metabolite levels in cancer: implications for tumour biology and cancer therapy
Lucas B. Sullivan, Dan Y. Gui & Matthew G. Vander Heiden
 
Determine the Metabolic Phenotype of Your Cells
The Agilent Seahorse XF Cell Energy Phenotype Test uses as few as 15,000 cells, and the Agilent Seahorse XFp Analyzer, to identify your cells' metabolic phenotype, as well as their metabolic potential — the relative utilization of mitochondrial respiration and glycolysis.
http://bit.ly/1Caw9Eq
Subscribe
 
Facebook
 
RSS
 
Recommend to library
 
Twitter
 
Advertisement
Epigenetics in Cancer: Translational Medicine Approaches
November 10, 2016
Presented by Roche and the New York Academy of Sciences. This conference will convene experts to explore epigenetic susceptibilities in cancer. Featuring a keynote address by Cornell's Dr. Chris Mason entitled "Single-Molecule and Single-Cell Epigenetics on Earth and in Space." Register.
 
Advertisement
Open for Submissions 

npj Precision Oncology is a new open access, online-only, peer-reviewed journal committed to publishing cutting-edge scientific research in all aspects of precision oncology from basic science to translational applications, to clinical medicine. The journal is part of the Nature Partner Journals series and published in partnership with The Hormel Institute, University of Minnesota. 

Explore the benefits of submitting your manuscript >>
 
Advertisement
Oncogenesis is an online-only, open access journal exploring the molecular basis of cancer and related phenomena. The journal seeks to promote diverse and integrated areas of molecular biology, cell biology, oncology, and genetics.

Explore the benefits of submitting your next research article.
 
RESEARCH HIGHLIGHTSTop

Tumour metabolism: Translating the undruggable target
p675 | doi:10.1038/nrc.2016.107
Three studies demonstrate the preclinical potential of a novel class of hypoxia-inducible factor 2α (HIF2α) antagonists in the treatment of von Hippel–Lindau (pVHL)-deficient clear cell renal cell carcinoma.
PDF


Tumour metabolism: Reflecting their origins
p676 | doi:10.1038/nrc.2016.106
Mayers, Torrence et al. show that lung tumours driven by oncogenic KRAS and loss of p53 depend on branched-chain amino acid metabolism, whereas pancreatic tumours driven by the same genetic defects do not.
PDF


Tumour metabolism: Lactic acid: not just a waste product?
p676 | doi:10.1038/nrc.2016.109
Brand and colleagues show that increased tumour lactate dehydrogenase A (LDHA)-mediated lactic acid production dampens activation and cytokine production of infiltrating T and natural killer (NK) cells allowing tumours to escape immune detection and promoting tumour growth.
PDF


Tumour metabolism: Building up and breaking down fatty acids
p677 | doi:10.1038/nrc.2016.111
Two studies have looked at the roles of fatty acid synthesis and oxidation, and their therapeutic potential, in cancer.
PDF


Cell differentiation: Pushing differentiation
p678 | doi:10.1038/nrc.2016.110
Cell differentiation blockade in the early stages of AML can be overcome by inhibiting dihydroorotate dehydrogenase
PDF



IN BRIEF

Tumour metabolism: Location matters | Immunotherapy: Checkpoint barriers | Tumour metabolism: Targeting proline metabolism? | Immunology: Skin inflammation predisposes to cancer
PDF

Cancer
JOBS of the week
Professor, Term Tenure - Department of Cancer Systems Imaging
The University of Texas MD Anderson Cancer Center
Chief, Cancer Data Science Laboratory, Tenure Eligible Position
National Institutes of Health (NIH), National Cancer Institute (NCI)
Cancer Biologist
Wake Forest Baptist Medical Center, Comprehensive Cancer Center
Principal Scientist - Imaging, Cancer Immunotherapy
F. Hoffmann-La Roche AG
858160 Group Leader Position in Pancreatic Cancer (fixed-term, 6 years)
Faculty of Health and Medical Sciences, the Danish Stem Cell Center, University of Copenhagen
More Science jobs from
Advertisement
Now included in PubMed Central

Online-only and open access, Cell Death Discovery publishes scientifically sound research at the intersection of cell death and medicine. Increasing the reproducibility of research, the journal fosters a dynamic dialogue with a focus on cancer, neurobiology and inflammation research.

Find out more: www.nature.com/cddiscovery/about
  Focus on: Tumour metabolism
REVIEWSTop
Altered metabolite levels in cancer: implications for tumour biology and cancer therapy
Lucas B. Sullivan, Dan Y. Gui & Matthew G. Vander Heiden
p680 | doi:10.1038/nrc.2016.85
Altered cancer cell metabolism can result in intracellular metabolite concentration changes. This Review discusses the mechanisms that lead to metabolite concentration changes in cancer cells, the consequences of these changes and how they might be exploited to improve cancer therapy.
Abstract | Full Text | PDF
Metabolic control of epigenetics in cancer
Adam Kinnaird, Steven Zhao, Kathryn E. Wellen & Evangelos D. Michelakis
p694 | doi:10.1038/nrc.2016.82
Alterations in the epigenome and metabolism bidirectionally regulate molecular rewiring in cancer cells. This Review discusses how metabolic remodelling can contribute to tumour epigenetic alterations, thereby affecting cancer cell differentiation, proliferation and/or apoptosis as well as therapeutic responses.
Abstract | Full Text | PDF
The metabolic fate of acetate in cancer
Zachary T. Schug, Johan Vande Voorde & Eyal Gottlieb
p708 | doi:10.1038/nrc.2016.87
This Review discusses how acetate functions as a nutritional source for tumours and as a regulator of cancer cell stress, and how preventing its (re)capture by cancer cells may provide an opportunity for therapeutic intervention.
Abstract | Full Text | PDF
The interplay between cell signalling and the mevalonate pathway in cancer
Peter J. Mullen et al.
p718 | doi:10.1038/nrc.2016.76
The mevalonate (MVA) pathway is an essential metabolic pathway that is affected by many oncogenic signalling pathways. This Review discusses the opportunity to immediately target the MVA pathway in cancer with agents approved for other therapeutic uses, such as statins.
Abstract | Full Text | PDF
The multifaceted roles of fatty acid synthesis in cancer
Florian Röhrig & Almut Schulze
p732 | doi:10.1038/nrc.2016.89
Lipid metabolism, especially fatty acid (FA) synthesis, is essential for membrane biosynthesis, energy storage and the generation of signalling molecules. This Review explores how FA synthesis promotes tumorigenesis and tumour progression and might be targeted therapeutically.
Abstract | Full Text | PDF | Supplementary information
Advertisement
Blood Cancer Journal is an online-only, open access journal, publishing high quality research on hematologic malignancies and related disorders.

Explore the benefits of submitting your next research article.
 
Corrigendum: From Krebs to clinic: glutamine metabolism to cancer therapy
Brian J. Altman, Zachary E. Stine & Chi V. Dang
p749 | doi:10.1038/nrc.2016.114
Full Text | PDF
Advertisement
Nature Outlook: Precision Medicine

Health care that is tailored on the basis of an individual?s genes, lifestyle or environment, is not a modern concept. But advances in genetics and the growing availability of health data for researchers and physicians promise to make this new era of medicine more personalized than ever before.

Access the Outlook free online

Sponsored by: Illumina, Inc.
 
 
nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com
More Nature Events
*2014 Journal Citation Report (Thomson Reuters, 2015)

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/myaccount
(You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department

For print subscription enquiries, please contact our subscription department

For other enquiries, please contact our feedback department

Nature Publishing Group | One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.

© 2016 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.

nature publishing group

No comments: